ARGX:NASDAQ
argenx SE - ADR
928,44 $
arrow_downward
-0,22%(-2,08) 1D
765,34 $
arrow_downward
-17,57% (-163,10)todayPre-market
Closed: 7 қаз., 16:00:01 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARGX...
Open
932,08 $
High
942,68 $
Low
921,72 $
Mkt. cap
58,78 млрд
Avg. vol.
259,69 м.
Volume
1,91 мың
P/E ratio
35,27
52-wk high
1 072,75 $
52-wk low
661,85 $
EPS
26,32 $
Beta
0,45
Shares outstanding
62,89 млн
No. of employees
2 мың
Open
932,08 $
High
942,68 $
Low
921,72 $
Mkt. cap
58,78 млрд
Avg. vol.
259,69 м.
Volume
1,91 мың
P/E ratio
35,27
52-wk high
1 072,75 $
52-wk low
661,85 $
EPS
26,32 $
Beta
0,45
Shares outstanding
62,89 млн
No. of employees
2 мың
News stories
From web sources and news partners
Yahoo Finance
·
38 минут бұрын
Argenx to Discontinue Late-Stage Sjogren's Disease Trial; Shares Down Pre-Bell
Benzinga
·
45 минут бұрын
Why Applied Digital Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
TipRanks
·
48 минут бұрын
Argenx Stock Sinks as Key Drug Trial Collapses
Yahoo Finance
·
1 сағат бұрын
Halozyme Therapeutics (HALO) Expands Argenx Deal, Is It Still 27% Below Fair Value?
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About argenx SE - ADR